437 related articles for article (PubMed ID: 24925721)
61. Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.
Pedigo CE; Ducasa GM; Leclercq F; Sloan A; Mitrofanova A; Hashmi T; Molina-David J; Ge M; Lassenius MI; Forsblom C; Lehto M; Groop PH; Kretzler M; Eddy S; Martini S; Reich H; Wahl P; Ghiggeri G; Faul C; Burke GW; Kretz O; Huber TB; Mendez AJ; Merscher S; Fornoni A
J Clin Invest; 2016 Sep; 126(9):3336-50. PubMed ID: 27482889
[TBL] [Abstract][Full Text] [Related]
62. Nonimmune cell-derived ICOS ligand functions as a renoprotective αvβ3 integrin-selective antagonist.
Koh KH; Cao Y; Mangos S; Tardi NJ; Dande RR; Lee HW; Samelko B; Altintas MM; Schmitz VP; Lee H; Mukherjee K; Peev V; Cimbaluk DJ; Reiser J; Hahm E
J Clin Invest; 2019 Apr; 129(4):1713-1726. PubMed ID: 30747722
[TBL] [Abstract][Full Text] [Related]
63. Rac1 activation in podocytes induces the spectrum of nephrotic syndrome.
Robins R; Baldwin C; Aoudjit L; Côté JF; Gupta IR; Takano T
Kidney Int; 2017 Aug; 92(2):349-364. PubMed ID: 28483380
[TBL] [Abstract][Full Text] [Related]
64. Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin.
Hladunewich MA; Cattran D; Sethi SM; Hayek SS; Li J; Wei C; Mullin SI; Reich HN; Reiser J; Fervenza FC
Kidney Int Rep; 2022 Jan; 7(1):68-77. PubMed ID: 35005315
[TBL] [Abstract][Full Text] [Related]
65. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis.
Huang J; Liu G; Zhang YM; Cui Z; Wang F; Liu XJ; Chu R; Zhao MH
BMC Med; 2014 May; 12():81. PubMed ID: 24884842
[TBL] [Abstract][Full Text] [Related]
66. The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury.
Zhang B; Shi W; Ma J; Sloan A; Faul C; Wei C; Reiser J; Yang Y; Liu S; Wang W
J Mol Med (Berl); 2012 Dec; 90(12):1407-20. PubMed ID: 23015147
[TBL] [Abstract][Full Text] [Related]
67. CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation.
Cara-Fuentes G; Araya C; Wei C; Rivard C; Ishimoto T; Reiser J; Johnson RJ; Garin EH
Nefrologia; 2013; 33(5):727-31. PubMed ID: 24089165
[TBL] [Abstract][Full Text] [Related]
68. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
[TBL] [Abstract][Full Text] [Related]
69. Contribution of podocyte inflammatory exosome release to glomerular inflammation and sclerosis during hyperhomocysteinemia.
Huang D; Li G; Zhang Q; Bhat OM; Zou Y; Ritter JK; Li PL
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166146. PubMed ID: 33862145
[TBL] [Abstract][Full Text] [Related]
70. The pathogenesis of focal segmental glomerulosclerosis.
Jefferson JA; Shankland SJ
Adv Chronic Kidney Dis; 2014 Sep; 21(5):408-16. PubMed ID: 25168829
[TBL] [Abstract][Full Text] [Related]
71. Angiopoietin-like 3 induces podocyte F-actin rearrangement through integrin α(V)β₃/FAK/PI3K pathway-mediated Rac1 activation.
Lin Y; Rao J; Zha XL; Xu H
Biomed Res Int; 2013; 2013():135608. PubMed ID: 24294595
[TBL] [Abstract][Full Text] [Related]
72. Modulation of radiation-induced damage of human glomerular endothelial cells by SMPDL3B.
Abou Daher A; Francis M; Azzam P; Ahmad A; Eid AA; Fornoni A; Marples B; Zeidan YH
FASEB J; 2020 Jun; 34(6):7915-7926. PubMed ID: 32293077
[TBL] [Abstract][Full Text] [Related]
73. Loss of Roundabout Guidance Receptor 2 (Robo2) in Podocytes Protects Adult Mice from Glomerular Injury by Maintaining Podocyte Foot Process Structure.
Pisarek-Horowitz A; Fan X; Kumar S; Rasouly HM; Sharma R; Chen H; Coser K; Bluette CT; Hirenallur-Shanthappa D; Anderson SR; Yang H; Beck LH; Bonegio RG; Henderson JM; Berasi SP; Salant DJ; Lu W
Am J Pathol; 2020 Apr; 190(4):799-816. PubMed ID: 32220420
[TBL] [Abstract][Full Text] [Related]
74. The glomerular permeability factors in idiopathic nephrotic syndrome.
Davin JC
Pediatr Nephrol; 2016 Feb; 31(2):207-15. PubMed ID: 25925039
[TBL] [Abstract][Full Text] [Related]
75. uPAR isoform 2 forms a dimer and induces severe kidney disease in mice.
Wei C; Li J; Adair BD; Zhu K; Cai J; Merchant M; Samelko B; Liao Z; Koh KH; Tardi NJ; Dande RR; Liu S; Ma J; Dibartolo S; Hägele S; Peev V; Hayek SS; Cimbaluk DJ; Tracy M; Klein J; Sever S; Shattil SJ; Arnaout MA; Reiser J
J Clin Invest; 2019 Apr; 129(5):1946-1959. PubMed ID: 30730305
[TBL] [Abstract][Full Text] [Related]
76. A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules.
Lee HW; Khan SQ; Faridi MH; Wei C; Tardi NJ; Altintas MM; Elshabrawy HA; Mangos S; Quick KL; Sever S; Reiser J; Gupta V
J Am Soc Nephrol; 2015 Nov; 26(11):2741-52. PubMed ID: 25858967
[TBL] [Abstract][Full Text] [Related]
77. c-Src is in the effector pathway linking uPAR and podocyte injury.
Kopp JB; Heymann J
J Clin Invest; 2019 Apr; 129(5):1827-1829. PubMed ID: 30939121
[TBL] [Abstract][Full Text] [Related]
78. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
79. Exosome Biogenesis and Lysosome Function Determine Podocyte Exosome Release and Glomerular Inflammatory Response during Hyperhomocysteinemia.
Huang D; Li G; Bhat OM; Zou Y; Li N; Ritter JK; Li PL
Am J Pathol; 2022 Jan; 192(1):43-55. PubMed ID: 34717894
[TBL] [Abstract][Full Text] [Related]
80. FHL2 mediates podocyte Rac1 activation and foot process effacement in hypertensive nephropathy.
Li SY; Chu PH; Huang PH; Hsieh TH; Susztak K; Tarng DC
Sci Rep; 2019 Apr; 9(1):6693. PubMed ID: 31040292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
